Russell Investments Group’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.3K Sell
4,329
-9,260
-68% -$31.4K ﹤0.01% 3882
2026
Q1
$56.8K Buy
13,589
+1,814
+15% +$7.57K ﹤0.01% 3281
2025
Q4
$50.8K Buy
11,775
+8,771
+292% +$33.5K ﹤0.01% 3297
2025
Q3
$13K Buy
+3,004
New +$13.5K ﹤0.01% 3722

Other funds holding SBC

Russell Investments Group's SBC Position: Q2 2026 in Review

Russell Investments Group reduced its SBC Medical Group (SBC) stake by 68% in Q2 2026, selling an estimated $31.4K and leaving 4,329 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3882.

Russell Investments Group first reported a position in SBC in Q3 2025 and has held it in 4 quarters since. The position peaked at $56.8K in Q1 2026. 56 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • Russell Investments Group held 4,329 shares of SBC Medical Group worth $13.3K as of Q2 2026.
  • Russell Investments Group sold 9,260 SBC Medical Group shares in Q2 2026, an estimated $31.4K.
  • SBC Medical Group made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3882 holding.
  • Russell Investments Group first reported a position in SBC Medical Group in Q3 2025 and has held it in 4 quarters since.
  • Russell Investments Group's SBC Medical Group position peaked at $56.8K in Q1 2026.
  • 56 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.